{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:38:28Z","timestamp":1794008308883,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s12014-025-09555-3","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:24:40Z","timestamp":1756722280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proteomic profiles in the aqueous following anti-vegf therapy in treatment na\u00efve neovascular age-related macular degeneration"],"prefix":"10.1186","volume":"22","author":[{"given":"Anne M.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinsey M.","family":"Trinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Westacott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebojsa","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"6","key":"9555_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMcp2102061","volume":"385","author":"RS Apte","year":"2021","unstructured":"Apte RS. Age-related macular degeneration. N Engl J Med. 2021;385(6):539\u201347.","journal-title":"N Engl J Med"},{"issue":"7","key":"9555_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017194","volume":"4","author":"JW Crabb","year":"2014","unstructured":"Crabb JW. The proteomics of drusen. Cold Spring Harb Perspect Med. 2014;4(7): a017194.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"9555_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844\u201351.","journal-title":"Ophthalmology"},{"key":"9555_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"NG Lambert","year":"2016","unstructured":"Lambert NG, ElShelmani H, Singh MK, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016;54:64\u2013102.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"9555_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134\u201343.","journal-title":"Nat Genet"},{"issue":"2","key":"9555_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, et al. Complement C3 inhibitor Pegcetacoplan for geographic atrophy secondary to Age-Related macular degeneration: A randomized phase 2 trial. Ophthalmology. 2020;127(2):186\u201395.","journal-title":"Ophthalmology"},{"issue":"4","key":"9555_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe GJ, Westby K, Csaky KG, et al. C5 inhibitor Avacincaptad Pegol for geographic atrophy due to Age-Related macular degeneration: A randomized pivotal phase 2\/3 trial. Ophthalmology. 2021;128(4):576\u201386.","journal-title":"Ophthalmology"},{"issue":"10","key":"9555_CR8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/eye.2015.159","volume":"29","author":"WM Amoaku","year":"2015","unstructured":"Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond). 2015;29(10):1397\u20138.","journal-title":"Eye (Lond)"},{"issue":"3","key":"9555_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/CS20040370","volume":"109","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci. 2005;109(3):227\u201341.","journal-title":"Clin Sci"},{"issue":"12","key":"9555_CR10","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","volume":"90","author":"RB Bhisitkul","year":"2006","unstructured":"Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol. 2006;90(12):1542\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"9555_CR11","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.12.8.1","volume":"12","author":"V Rajeswaren","year":"2023","unstructured":"Rajeswaren V, Wagner BD, Patnaik JL, et al. Interleukin-4 plasma levels stratified by sex in intermediate age-related macular degeneration and geographic atrophy. Transl Vis Sci Technol. 2023;12(8): 1.","journal-title":"Transl Vis Sci Technol"},{"key":"9555_CR12","volume":"3","author":"JC Rohloff","year":"2014","unstructured":"Rohloff JC, Gelinas AD, Jarvis TC, et al. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol Ther. 2014;3: e201.","journal-title":"Mol Ther"},{"issue":"4","key":"9555_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ajog.2015.11.001","volume":"214","author":"AM Lynch","year":"2016","unstructured":"Lynch AM, Wagner BD, Deterding RR, et al. The relationship of Circulating proteins in early pregnancy with preterm birth. Am J Obstet Gynecol. 2016;214(4):517. e1- e8.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"9555_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5(12): e15004.","journal-title":"PLoS One"},{"issue":"10","key":"9555_CR15","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.10.12","volume":"9","author":"AM Lynch","year":"2020","unstructured":"Lynch AM, Wagner BD, Palestine AG, et al. Plasma biomarkers of reticular pseudodrusen and the risk of progression to advanced age-related macular degeneration. Transl Vis Sci Technol. 2020;9(10): 12.","journal-title":"Transl Vis Sci Technol"},{"issue":"1\u20132","key":"9555_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1\u20132):279\u201384.","journal-title":"Behav Brain Res"},{"issue":"2","key":"9555_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1167\/iovs.15-18245","volume":"57","author":"H Takahashi","year":"2016","unstructured":"Takahashi H, Nomura Y, Nishida J, et al. Vascular endothelial growth factor (VEGF) concentration is underestimated by enzyme-linked immunosorbent assay in the presence of anti-VEGF drugs. Invest Ophthalmol Vis Sci. 2016;57(2):462\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"9555_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12195-020-00641-0","volume":"13","author":"R Kureshi","year":"2020","unstructured":"Kureshi R, Zhu A, Shen J, et al. Structure-guided molecular engineering of a vascular endothelial growth factor antagonist to treat retinal diseases. Cell Mol Bioeng. 2020;13(5):405\u201318.","journal-title":"Cell Mol Bioeng"},{"issue":"7","key":"9555_CR19","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","volume":"35","author":"I Goncalves","year":"2015","unstructured":"Goncalves I, Bengtsson E, Colhoun HM, et al. Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2015;35(7):1723\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9555_CR20","unstructured":"Reactome. 2022 [cited 2022 2\/17\/2022]. Available from: https:\/\/reactome.org\/"},{"issue":"3","key":"9555_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1242\/dev.085621","volume":"140","author":"H Liang","year":"2013","unstructured":"Liang H, Xiao G, Yin H, et al. Neural development is dependent on the function of specificity protein 2 in cell cycle progression. Development. 2013;140(3):552\u201361.","journal-title":"Development"},{"issue":"6","key":"9555_CR22","doi-asserted-by":"publisher","first-page":"C1214","DOI":"10.1152\/ajpcell.00036.2022","volume":"322","author":"JAN Meester","year":"2022","unstructured":"Meester JAN, De Kinderen P, Verstraeten A, et al. The role of Biglycan in the healthy and thoracic aneurysmal aorta. Am J Physiol Cell Physiol. 2022;322(6):C1214\u201322.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"9555_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1074\/jbc.M115.681775","volume":"291","author":"B Pilecki","year":"2016","unstructured":"Pilecki B, Holm AT, Schlosser A, et al. Characterization of microfibrillar-associated protein 4 (MFAP4) as a tropoelastin- and fibrillin-binding protein involved in elastic fiber formation. J Biol Chem. 2016;291(3):1103\u201314.","journal-title":"J Biol Chem"},{"key":"9555_CR24","unstructured":"Pilecki BSA, Hua J, Andersen TL, Heegaard S, Bates DO, Holmskov U, Sorensen GL. Choroidal and retinal expression of microfibrillar-associated protein 4 (MFAP4) in neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR). ARVO annual meeting June 2020. Investigative Ophthalmology & Visual Science. 2020."},{"issue":"5","key":"9555_CR25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/ijmm.2020.4516","volume":"45","author":"K Zhang","year":"2020","unstructured":"Zhang K, Li M, Yin L, et al. Role of thrombospondin\u20131 and thrombospondin\u20132 in cardiovascular diseases (Review). Int J Mol Med. 2020;45(5):1275\u201393.","journal-title":"Int J Mol Med"},{"issue":"2","key":"9555_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/europace\/euab124","volume":"24","author":"H Wang","year":"2022","unstructured":"Wang H, Liu M, Wang X, et al. MFAp4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation. Europace. 2022;24(2):340\u20137.","journal-title":"Europace"},{"issue":"3","key":"9555_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.5114\/aoms.2018.74953","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang X, Li H, Kou W, et al. Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left atrial remodelling. Arch Med Sci. 2019;15(3):632\u201340.","journal-title":"Arch Med Sci"},{"issue":"7","key":"9555_CR28","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/liv.14491","volume":"40","author":"BS Madsen","year":"2020","unstructured":"Madsen BS, Thiele M, Detlefsen S, et al. Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4. Liver Int. 2020;40(7):1701\u201312.","journal-title":"Liver Int"},{"issue":"1","key":"9555_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-016-0952-3","volume":"14","author":"T Bracht","year":"2016","unstructured":"Bracht T, M\u00f6lleken C, Ahrens M, et al. Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients. J Transl Med. 2016;14(1):201.","journal-title":"J Transl Med"},{"issue":"11","key":"9555_CR30","doi-asserted-by":"publisher","first-page":"14250","DOI":"10.1096\/fj.202001026R","volume":"34","author":"Z Pan","year":"2020","unstructured":"Pan Z, Yang K, Wang H, et al. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-\u03baB and TGF-\u03b2\/Smad signaling pathways. FASEB J. 2020;34(11):14250\u201363.","journal-title":"FASEB J"},{"key":"9555_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-94-017-9153-3_2","volume":"819","author":"H Gardner","year":"2014","unstructured":"Gardner H. Integrin \u03b11\u03b21. Adv Exp Med Biol. 2014;819:21\u201339.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"9555_CR32","first-page":"298","volume":"72","author":"Y Takakuwa","year":"2000","unstructured":"Takakuwa Y. Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: structure and functions in erythrocytes and nonerythroid cells. Int J Hematol. 2000;72(3):298\u2013309.","journal-title":"Int J Hematol"},{"issue":"6","key":"9555_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.exer.2010.08.013","volume":"91","author":"RO Parker","year":"2010","unstructured":"Parker RO, Crouch RK. Retinol dehydrogenases (RDHs) in the visual cycle. Exp Eye Res. 2010;91(6):788\u201392.","journal-title":"Exp Eye Res"},{"issue":"6","key":"9555_CR34","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.6.1","volume":"8","author":"SR Crowell","year":"2019","unstructured":"Crowell SR, Wang K, Famili A, et al. Influence of charge, hydrophobicity, and size on vitreous pharmacokinetics of large molecules. Transl Vis Sci Technol. 2019;8(6): 1.","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"9555_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4155\/bio-2018-0096","volume":"11","author":"G Sumner","year":"2019","unstructured":"Sumner G, Georgaros C, Rafique A, et al. Anti-VEGF drug interference with VEGF quantitation in the R&d systems human quantikine VEGF ELISA kit. Bioanalysis. 2019;11(5):381\u201392.","journal-title":"Bioanalysis"},{"issue":"52","key":"9555_CR36","doi-asserted-by":"publisher","first-page":"18902","DOI":"10.1073\/pnas.0509069102","volume":"102","author":"JH Lee","year":"2005","unstructured":"Lee JH, Canny MD, De Erkenez A, et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A. 2005;102(52):18902\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9555_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000490153","volume":"241","author":"T Mimura","year":"2019","unstructured":"Mimura T, Funatsu H, Noma H, et al. Aqueous humor levels of cytokines in patients with age-related macular degeneration. Ophthalmologica. 2019;241(2):81\u20139.","journal-title":"Ophthalmologica"},{"key":"9555_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/aos.14537","volume":"99","author":"SA Minaker","year":"2021","unstructured":"Minaker SA, Mason RH, Lahaie Luna G, et al. Changes in aqueous and vitreous inflammatory cytokine levels in neovascular age-related macular degeneration: a systematic review and meta-analysis. Acta Ophthalmol. 2020. https:\/\/doi.org\/10.1111\/aos.14537","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"9555_CR39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/s41598-018-19594-6","volume":"8","author":"T Sato","year":"2018","unstructured":"Sato T, Takeuchi M, Karasawa Y, et al. Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor. Sci Rep. 2018;8(1):1098.","journal-title":"Sci Rep"},{"issue":"5","key":"9555_CR40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/eye.2016.328","volume":"31","author":"T Schick","year":"2017","unstructured":"Schick T, Steinhauer M, Aslanidis A, et al. Local complement activation in aqueous humor in patients with age-related macular degeneration. Eye (Lond). 2017;31(5):810\u20133.","journal-title":"Eye (Lond)"},{"key":"9555_CR41","doi-asserted-by":"publisher","first-page":"677707","DOI":"10.3389\/fimmu.2021.677707","volume":"12","author":"AC Bouwman","year":"2021","unstructured":"Bouwman AC, van Daalen KR, Crnko S, et al. Intracellular and extracellular roles of granzyme K. Front Immunol. 2021;12:677707.","journal-title":"Front Immunol"},{"key":"9555_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2019.12.002","volume":"218","author":"M Sikora","year":"2020","unstructured":"Sikora M, Kope\u0107 B, Piotrowska K, et al. Role of allograft inflammatory factor-1 in pathogenesis of diseases. Immunol Lett. 2020;218:1\u20134.","journal-title":"Immunol Lett"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-025-09555-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:39:33Z","timestamp":1757468373000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-025-09555-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9555"],"URL":"https:\/\/doi.org\/10.1186\/s12014-025-09555-3","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nebojsa Janjic, Daniel Drolet, Kinsey Trinder, Matt Westacott, and Shashi Gupta are employees and stakeholders of SomaLogic, Inc. Dr. Mandava is an advisor to SomaLogic. None of the other authors have any proprietary interests or conflicts of interest related to this submission. Potential influence of these co-authors on the content of the manuscript was mitigated by co-authors (to include the lead and senior author) who had no links with SomaLogic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Nebojsa Janjic, Daniel Drolet, Kinsey Trinder, Matt Westacott, and Shashi Gupta are employees and stakeholders of SomaLogic, Inc. Dr. Mandava is an advisor to SomaLogic. None of the other authors have any proprietary interests or conflicts of interest related to this submission. Potential influence of these co-authors on the content of the manuscript was mitigated by co-authors (to include the lead and senior author) who had no links with SomaLogic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Commercial relationships disclosure"}}],"article-number":"32"}}